Charbel Said Eid

Title: Charbel Said Eid: Innovator in Cell-Free DNA Isolation

Introduction

Charbel Said Eid is a notable inventor based in Millbrae, CA (US). He has made significant contributions to the field of molecular biology, particularly in the isolation of cell-free DNA. His innovative methods have the potential to enhance the efficiency and cost-effectiveness of DNA analysis.

Latest Patents

Charbel Said Eid holds a patent for "Methods for isolating cell-free DNA." This patent discloses methods for isolating DNA, including cell-free DNA (cfDNA) or DNA from tissue samples. The process involves partitioning DNA into hypermethylated and hypomethylated partitions. After differential tagging of these partitions, portions of the hypomethylated partition are pooled with the hypermethylated partition or pooled separately. This approach allows for the capture of epigenetic and sequence-variable target regions, ultimately reducing costs and bandwidth by limiting sequencing of less informative DNA.

Career Highlights

Charbel Said Eid is currently associated with Guardant Health, Inc., where he applies his expertise in DNA isolation methods. His work is pivotal in advancing the capabilities of genomic analysis and personalized medicine. With a focus on innovative solutions, he continues to contribute to the scientific community.

Collaborations

Charbel collaborates with talented individuals such as Ariel Jaimovich and Sven Jeffrey Duenwald. These partnerships enhance the research and development efforts at Guardant Health, Inc., fostering an environment of innovation and discovery.

Conclusion

Charbel Said Eid is a distinguished inventor whose work in cell-free DNA isolation is paving the way for advancements in genomic research. His contributions are vital for improving the efficiency of DNA analysis, making a significant impact in the field of molecular biology.